|
|
||||||||
Department of Internal Medicine, Justus-Liebig-University Giessen, 35392 Giessen, Germany
Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion to ventilation, thus optimizing gas exchange. NADPH oxidase-related superoxide anion generation has been suggested as part of the signaling response to hypoxia. Because protein kinase (PK) C activation can occur during hypoxia and PKC activation is known to be critical for NADPH oxidase stimulation in different cell types, we probed the role of PKC in hypoxic vasoconstriction in intact rabbit lungs. Control vasoconstrictor responses were elicited by angiotensin II (ANG II) and the stable thromboxane analog U-46619. Portions of the experiments were performed while NO synthesis and prostanoid generation were blocked with NG-monomethyl-L-arginine and acetylsalicylic acid to avoid confounding effects due to interference with these vasoactive mediators. The PKC inhibitor H-7 (10-50 µM) caused dose-dependent inhibition of HPV, but this agent lacked specificity because ANG II- and U-46619-induced vasoconstrictions were correspondingly suppressed. In contrast, low concentrations of the specific PKC inhibitor bisindolylmaleimide I (BIM; 1-15 µM) strongly inhibited the hypoxic vasoconstriction without any interference with the responses to the pharmacological agents. Superimposable dose-inhibition curves were also obtained for BIM when lung NO synthesis and prostanoid generation were blocked throughout the experiments. Under either condition, BIM did not affect normoxic vascular tone. The PKC activator farnesylthiotriazole (FTT), ascertained to stimulate rabbit NADPH oxidase by provocation of alveolar macrophage superoxide anion generation in vitro, caused rapid-onset, transient pressor responses in normoxic lungs. After FTT, the hypoxic vasoconstrictor response was totally suppressed, in contrast to the largely maintained pressor responses to ANG II and U-46619. The lungs became refractory even to delayed hypoxic challenges after FTT application. In conclusion, these data support the concept that activation of PKC is involved in the transduction pathway forwarding pulmonary vasoconstriction in response to alveolar hypoxia.
hypoxia; isolated lung; nitric oxide; pulmonary hypertension; rabbit
This article has been cited by other articles:
![]() |
S. Earley, S. V. Straub, and J. E. Brayden Protein kinase C regulates vascular myogenic tone through activation of TRPM4 Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2613 - H2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. John, B. O. Ibe, and J. Usha Raj Oxygen alters caveolin-1 and nitric oxide synthase-3 functions in ovine fetal and neonatal lung microvascular endothelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1079 - L1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. V. Mammen, J. C. Song, J. Yoo, P. S. Kim, H. W. Davis, M. I. Calvo, R. T. Worrell, K. S. Matlin, and J. B. Matthews Differential subcellular targeting of PKC-{epsilon} in response to pharmacological or ischemic stimuli in intestinal epithelia Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G135 - G142. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Tsai, M. Wang, J. M. Pitcher, K. K. Meldrum, and D. R. Meldrum Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1215 - L1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Littler, K. G. Morris Jr., K. A. Fagan, I. F. McMurtry, R. O. Messing, and E. C. Dempsey Protein kinase C-epsilon -null mice have decreased hypoxic pulmonary vasoconstriction Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1321 - H1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Karamsetty, J. R. Klinger, and N. S. Hill Evidence for the role of p38 MAP kinase in hypoxia-induced pulmonary vasoconstriction Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L859 - L866. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Barman Effect of protein kinase C inhibition on hypoxic pulmonary vasoconstriction Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L888 - L895. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Weissmann, S. Winterhalder, M. Nollen, R. Voswinckel, K. Quanz, H. A. Ghofrani, R. T. Schermuly, W. Seeger, and F. Grimminger NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L638 - L645. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Weissmann, A. Tadic, J. Hanze, F. Rose, S. Winterhalder, M. Nollen, R. T. Schermuly, H. A. Ghofrani, W. Seeger, and F. Grimminger Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H2O2? Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L683 - L690. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Summers, J. L. Overholt, and N. R. Prabhakar Augmentation of L-Type Calcium Current by Hypoxia in Rabbit Carotid Body Glomus Cells: Evidence for a PKC-Sensitive Pathway J Neurophysiol, September 1, 2000; 84(3): 1636 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Bian, W.-M. Zhang, J.-M. Pei, and T.-M. Wong The Role of Phosphodiesterase in Mediating the Effect of Protein Kinase C on Cyclic AMP Accumulation upon kappa -Opioid Receptor Stimulation in the Rat Heart J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1065 - 1070. [Abstract] [Full Text] |
||||
![]() |
T. Kawaguchi, R. L. Veech, and K. Uyeda Regulation of Energy Metabolism in Macrophages during Hypoxia. ROLES OF FRUCTOSE 2,6-BISPHOSPHATE AND RIBOSE 1,5-BISPHOSPHATE J. Biol. Chem., July 20, 2001; 276(30): 28554 - 28561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |